$HRGN
Harvard Apparatus Regenerative Technology Inc

2014 Q4 Form 10-Q Financial Statement

#000114420414067953 Filed on November 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q4
Revenue $45.00K $2.000K $22.00K
YoY Change 104.55%
Cost Of Revenue $23.00K $1.000K $11.00K
YoY Change 109.09%
Gross Profit $22.00K $1.000K $11.00K
YoY Change 100.0%
Gross Profit Margin 48.89% 50.0% 50.0%
Selling, General & Admin $1.580M $1.276M $1.580M
YoY Change 0.0% 27.35% 64.58%
% of Gross Profit 7181.82% 127600.0% 14363.64%
Research & Development $1.290M $1.401M $1.080M
YoY Change 19.44% 32.42% 8.0%
% of Gross Profit 5863.64% 140100.0% 9818.18%
Depreciation & Amortization $100.0K $110.0K $40.00K
YoY Change 150.0% 175.0% 100.0%
% of Gross Profit 454.55% 11000.0% 363.64%
Operating Expenses $2.864M $2.677M $2.659M
YoY Change 7.71% 29.95% 35.25%
Operating Profit -$2.842M -$2.676M -$2.648M
YoY Change 7.33% 29.9% 34.69%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 -$4.000K $0.00
YoY Change
Pretax Income -$2.842M -$2.680M -$2.648M
YoY Change 7.33% 30.1% 34.42%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.842M -$2.680M -$2.648M
YoY Change 7.33% 30.1% 34.42%
Net Earnings / Revenue -6315.56% -134000.0% -12036.36%
Basic Earnings Per Share
Diluted Earnings Per Share -$7.282M -$6.872M -$6.795M
COMMON SHARES
Basic Shares Outstanding 7.857M shares 7.847M shares 7.740M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.270M $7.720M $14.01M
YoY Change -62.38%
Cash & Equivalents $5.272M $7.722M $14.01M
Short-Term Investments
Other Short-Term Assets $30.00K $0.00
YoY Change 0.0%
Inventory $207.0K $160.0K $38.00K
Prepaid Expenses $317.0K $117.0K $421.0K
Receivables $5.000K $30.00K
Other Receivables $20.00K $0.00
Total Short-Term Assets $5.828M $8.058M $14.49M
YoY Change -59.78% 24318.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.376M $1.354M $575.0K
YoY Change 139.3% 194.35% 31.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.376M $1.354M $575.0K
YoY Change 139.3% 194.35% 31.28%
TOTAL ASSETS
Total Short-Term Assets $5.828M $8.058M $14.49M
Total Long-Term Assets $1.376M $1.354M $575.0K
Total Assets $7.204M $9.412M $15.06M
YoY Change -52.18% 1809.13% 3339.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $370.0K $254.0K $244.0K
YoY Change 51.64% 101.59% 36.31%
Accrued Expenses $320.0K $430.0K $160.0K
YoY Change 100.0% 72.0% -30.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $710.0K $716.0K $495.0K
YoY Change 43.43% 88.92% 20.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $710.0K $716.0K $495.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $710.0K $716.0K $495.0K
YoY Change 43.43% 88.92% 20.44%
SHAREHOLDERS EQUITY
Retained Earnings -$13.04M -$10.19M -$1.974M
YoY Change 560.33% -45.1%
Common Stock $79.00K $79.00K $77.00K
YoY Change 2.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.494M $8.696M $14.57M
YoY Change
Total Liabilities & Shareholders Equity $7.204M $9.412M $15.06M
YoY Change -52.18% 1820.82% 3339.27%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q4
OPERATING ACTIVITIES
Net Income -$2.842M -$2.680M -$2.648M
YoY Change 7.33% 30.1% 34.42%
Depreciation, Depletion And Amortization $100.0K $110.0K $40.00K
YoY Change 150.0% 175.0% 100.0%
Cash From Operating Activities -$2.320M -$1.860M -$2.090M
YoY Change 11.0% 5.08% 36.6%
INVESTING ACTIVITIES
Capital Expenditures -$130.0K -$530.0K -$150.0K
YoY Change -13.33% 430.0% -6.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$130.0K -$530.0K -$150.0K
YoY Change -13.33% 430.0% -6.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 60.00K 16.25M
YoY Change -100.0% -96.77% 861.54%
NET CHANGE
Cash From Operating Activities -2.320M -1.860M -2.090M
Cash From Investing Activities -130.0K -530.0K -150.0K
Cash From Financing Activities 0.000 60.00K 16.25M
Net Change In Cash -2.450M -2.330M 14.01M
YoY Change -117.49% 23200.0%
FREE CASH FLOW
Cash From Operating Activities -$2.320M -$1.860M -$2.090M
Capital Expenditures -$130.0K -$530.0K -$150.0K
Free Cash Flow -$2.190M -$1.330M -$1.940M
YoY Change 12.89% -20.36% 41.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Assets
Assets
15064000 USD
CY2014Q3 us-gaap Assets
Assets
9412000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
244000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
254000 USD
CY2014Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1354000 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
575000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
575000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
38000 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
15000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7000 USD
CY2014Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
157000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
31000 USD
CY2014Q3 us-gaap Cash
Cash
7722000 USD
CY2013Q4 us-gaap Cash
Cash
14008000 USD
CY2014Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
3000 USD
CY2013Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
22000 USD
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
117000 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
421000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
8058000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14489000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1354000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
77000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4165000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
974000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1199000 USD
us-gaap Operating Expenses
OperatingExpenses
8238000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2060000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2677000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8215000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2060000 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7809 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7742080 shares
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
248 USD
CY2014Q3 us-gaap Revenues
Revenues
2000 USD
us-gaap Cost Of Revenue
CostOfRevenue
25000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
1000 USD
us-gaap Gross Profit
GrossProfit
23000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3832000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1058000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1401000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
241000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2676000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8219000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2060000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2680000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-8219000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2680000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2014Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
32000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
90000 USD
CY2014Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
430000 USD
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
161000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
716000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
495000 USD
CY2014Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2014Q3 us-gaap Liabilities
Liabilities
716000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
495000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
79000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
77000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18810000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16466000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10193000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1974000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
8696000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
14569000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9412000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15064000 USD
hart Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7856607 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7742080 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7856607 shares
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
504 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
48000 USD
CY2013Q3 us-gaap Revenues
Revenues
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3483000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
82000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2604000 USD
us-gaap Operating Expenses
OperatingExpenses
6169000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6169000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6169000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-6169000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7740 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7740 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7851 shares
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8219000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2060000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2683000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1926000 USD
us-gaap Depreciation
Depreciation
256000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-19000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-304000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-58000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
269000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5671000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1033000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1033000 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
418000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6286000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14008000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7722000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
119000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
418000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6169000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
514000 USD
us-gaap Depreciation
Depreciation
123000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
33000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-53000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
21000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5597000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-145000 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
5742000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5742000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2014Q3 us-gaap Other Receivables
OtherReceivables
29000 USD
CY2013Q4 us-gaap Other Receivables
OtherReceivables
0 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
30000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
29000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
30000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Harvard Apparatus Regenerative Technology, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001563665
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
HART
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7856607 shares

Files In Submission

Name View Source Status
0001144204-14-067953-index-headers.html Edgar Link pending
0001144204-14-067953-index.html Edgar Link pending
0001144204-14-067953.txt Edgar Link pending
0001144204-14-067953-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hart-20140930.xml Edgar Link completed
hart-20140930.xsd Edgar Link pending
hart-20140930_cal.xml Edgar Link unprocessable
hart-20140930_def.xml Edgar Link unprocessable
hart-20140930_lab.xml Edgar Link unprocessable
hart-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v393708_10q.htm Edgar Link pending
v393708_ex31-1.htm Edgar Link pending
v393708_ex31-2.htm Edgar Link pending
v393708_ex32-1.htm Edgar Link pending
v393708_ex32-2.htm Edgar Link pending